Rankings
▼
Calendar
NTLA Q1 2016 Earnings — Intellia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
NTLA
Intellia Therapeutics, Inc.
$2B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
-$3M
-194.0% margin
Operating Income
-$7M
-376.7% margin
Net Income
-$7M
-376.4% margin
EPS (Diluted)
$-0.20
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$10M
Stock-Based Comp.
$812,000
Balance Sheet
Total Assets
$76M
Total Liabilities
$103M
Stockholders' Equity
-$27M
Cash & Equivalents
$64M
← FY 2016
All Quarters
Q2 2016 →
